Bromopride

Oral
Gastrointestinal motility disorders, Nausea and vomiting

Parenteral
Gastrointestinal motility disorders, Nausea and vomiting

GI haemorrhage, obstruction, perforation or immediately after surgery. Patients with pheochromocytoma.

Children, young patients, elderly; renal impairment, epilepsy, Parkinson's disease; history of depression. May impair ability to drive or operate machinery.

Extrapyramidal symptoms; restlessness, drowsiness, diarrhoea; hypotension, hypertension, dizziness, headache, depression; galactorrhoea.
Potentially Fatal: Neuroleptic malignant syndrome.

Other centrally active drugs and those with extrapyramidal effects. Increased toxicity with lithium. Antagonism of GI effects with antimuscarinics and opioid analgesics. May affect absorption of other drugs.

Transient increase in plasma-aldosterone concentration.

Description:
Mechanism of Action: Bromopride is a substituted benzamide with prokinetic and antiemetic properties.

GIT Regulators, Antiflatulents & Anti-Inflammatories